Results 41 to 50 of about 10,503 (121)

Etest for assessing the susceptibility of filamentous fungi

open access: yes, 2004
The purpose of this study was to evaluate the Etest as an in vitro antifungal susceptibility test method for different moulds originating from human samples and from the environment. A total of 50 isolates (1 Acremonium, 18 Aspergillus, 2 Cladosporium, 1
Dóczi, Ilona   +11 more
core   +1 more source

Awareness of Microbiological Safety in Playgrounds Amid Rising Antibiotic Resistance

open access: yesEnvironmental Microbiology Reports, Volume 17, Issue 6, December 2025.
Playgrounds are identified as reservoirs for antibiotic‐resistant bacteria, posing a potential public health risk. Despite the existence of safety regulations for playground equipment, microbiological safety is treated superficially. Global strategies, including hygiene practices and antibacterial materials, are needed to reduce the spread of ...
Rafał Łopucki   +4 more
wiley   +1 more source

Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study. [PDF]

open access: yes, 2016
peer reviewedOBJECTIVES: To compare the concordance of ceftaroline MIC values by reference broth microdilution (BMD) and Etest (bioMérieux, France) for MSSA and MRSA isolates obtained from PREMIUM (D372SL00001), a European multicentre study. METHODS:
Cristino, M   +207 more
core   +1 more source

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 6, Page 386-392, June 2025.
Abstract Introduction Treatment of infections in patients with burn injuries is challenging due to altered antimicrobial pharmacokinetics. Continuous infusion β‐lactam therapy may be a useful antimicrobial stewardship strategy to improve pharmacodynamic target attainment in this population.
Jay D. Olivet   +8 more
wiley   +1 more source

Evaluation of Etest® strips for detection of KPC and metallo-carbapenemases in Enterobacteriaceae

open access: yes, 2013
The performance of Etest KPC and MBL strips (bioMérieux) was evaluated as compared to other phenotypic tests for detecting carbapenemases of the KPC-type and metallo-β-lactamases, respectively, on 133 well-characterized enterobacterial isolates.
Halimi, Diane   +3 more
core   +1 more source

Antifungal Resistance in Non‐fumigatus Aspergillus Species

open access: yesMycoses, Volume 68, Issue 4, April 2025.
ABSTRACT This review provides an in‐depth exploration of antifungal resistance in non‐fumigatus Aspergillus species, mainly focusing on acquired resistance. The available data have been compiled and sometimes re‐analysed. It highlights the increasing prevalence of resistance in non‐fumigatus species belonging to Flavi, Terrei, Nigri, and Nidulantes ...
Elie Djenontin   +3 more
wiley   +1 more source

Prueba Epsilon (Etest)

open access: yes, 1998
Etest (AB Biodisk, Solna, Sweden) is an agar based method for susceptibility testing, created to overcome the disadvantages of the disc diffusion and conventional dilution methods while retaining the favorable aspects of both procedures.
Jaramillo Velásquez, Sergio
core  

Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci

open access: yes, 2023
Eravacycline (ERV) (brand name Xerava [Tetraphase]) is a new tetracycline-class antibacterial that has been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for treatment of complicated intra-abdominal ...
Emery, Christopher L.   +6 more
core   +1 more source

Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales

open access: yes, 2022
Plazomicin (PLZ), brand name ZEMDRI (Cipla Therapeutics), is a novel aminoglycoside antibiotic approved by the U.S. Food and Drug Administration (FDA) for treatment of complicated urinary tract infections including pyelonephritis.
Emery, Christopher L.   +9 more
core   +1 more source

Evaluation of Etest Method for Determining Isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans [PDF]

open access: yes, 2008
We compared Etest with broth microdilution testing for isavuconazole activity against 92 Cryptococcus isolates. A 97.8 % agreement was found between these methods, without major discrepancies (>2-well dilution difference). Our findings support the use
Nathan P. Wiederhold   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy